Malondialdehyde-specific IGM antibodies define residual atherothrombotic risk

Autor: Koller, T., Afonyushkin, T., Oszvar-Kozma, M., Taqi, S., Hoke, M., Binder, C.
Zdroj: In Atherosclerosis August 2023 379 Supplement 1:S12-S12
Databáze: ScienceDirect